Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kimia Ara Heram is a prominent Iranian pharmaceutical company specializing in the manufacturing, marketing, and distribution of high-quality healthcare products. Established in 2005, the company operates across diverse therapeutic areas including oncology, nephrology, hematology, and cardiology. They are well-known for their portfolio of iron supplements and renal care products, often collaborating with international partners to bring advanced therapies to the Iranian market. The company maintains a strong presence in both the retail and hospital sectors, supported by a dedicated manufacturing facility and a robust distribution network. Kimia Ara Heram focuses on providing cost-effective and innovative solutions to meet the needs of patients with chronic conditions. Their commitment to quality is reflected in their GMP-certified operations and strategic alliances with global pharmaceutical leaders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kimia Ara Heram.